KNSA Competitors & Alternatives

Compare Kiniksa Pharmaceuticals Ltd with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

KNSA

Main Stock
$62.17
Tradestie Score
65
Market Cap
$2.86B
P/E Ratio
69.7
Revenue Growth
0.6%
Analyst Upside
+6.2%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
RYTM Rhythm Pharmaceuticals, Inc. Common Stock
$107.60
$6.64B - 55 Compare
KRYS Krystal Biotech, Inc. Common Stock
$344.76
$5.20B 49.0 59 Compare
ALKS Alkermes Inc. plc
$51.34
$5.06B 57.7 61 Compare
CRNX Crinetics Pharmaceuticals, Inc.
$83.72
$3.92B - 55 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$119.79
$3.67B - 62 Compare
LNTH Lantheus Holdings, Inc
$103.03
$3.51B 25.2 51 Compare
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock
$17.00
$3.26B 46.0 53 Compare
PBH Prestige Consumer Healthcare Inc.
$47.58
$3.12B 12.5 58 Compare
PRGO PERRIGO COMPANY PLC
$10.00
$3.10B - 58 Compare
INDV Indivior PLC Ordinary Shares
$40.40
$2.93B 20.8 61 Compare

Data updated: Jul 14, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry